Latest filing published 10 Jun 2024 for Medicenna Therapeutics Corp., €89k. Read the official filing
Rosemina MERCHANT is a declared insider of Medicenna Therapeutics Corp., with filings sourced from SEDI. In total, 5 filings cover trades dated from 1 March 2017 to 3 June 2024.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 10 June 2024, the filings show an option exercise worth €89k in Medicenna Therapeutics Corp. The median gap between a trade and its publication by SEDI is 6 days. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations